DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Requip (Ropinirole Hydrochloride) - Current Clinical Trials

 
 



Requip Related Clinical Trials

A Comparison of Ropinirole Immediate Release With Ropinirole Prolonged Release in Patients With Advanced Parkinson's [Completed]

Study to Observe the Effect of Requip PD® Once-daily (QD) Versus Twice-daily (BID) [Recruiting]

Converting From Ropinirole Immediate Release (IR) To Ropinirole Controlled-Release for RLS (Restless Legs Syndrome) [Completed]

Treating Sexual Dysfunction From SSRI Medication: a Study Comparing Requip CR to Placebo [Active, not recruiting]

Long-Term Extension Study Evaluating Extended Release Ropinirole XL (Formerly Referred to as Ropinirole CR) in Patients Who Already Completed Either Study 167 or 164 [Active, not recruiting]

An Open-Label Continuation Study Evaluating the Long-Term Safety of Extended Release Ropinirole XL (Formerly CR) in Parkinson''s Disease [Active, not recruiting]

RLS In Adults: Comparing Immediate Release Formulation With Extended Release Formulation Of Ropinirole [Active, not recruiting]

SWITCH:Restless Legs Patients Switched to Ropinirole From Pramipexole [Recruiting]

Parkinson's Disease Patient Study On Absorption, Distribution, Metabolism And Excretion Of Ropinirole [Completed]

Open Label High Dose Ropinirole (Requip) Study for Patients With Parkinson's Disease [Recruiting]

The Effects Of Ropinirole On Mood Or Mild Depression In Patients With Moderate To Severe Restless Legs Syndrome [Completed]

Restless Legs Patient Study On Absorption, Distribution, Metabolism And Excretion Of Ropinirole And The Effect Of Food [Completed]

Ropinirole in the Treatment of Bipolar Depression [Recruiting]

A Fixed Dose, Dose Response Study for Ropinirole Prolonged Release in Patients With Early Stage Parkinson's Disease [Recruiting]

A Phase III, Randomised, Double-blind, Placebo-controlled, Parallel Group Study of Six Months Treatment With Ropinirole PR as Adjunctive Therapy in Patients With Parkinson's Disease Who Are Not Optimally Controlled on L-Dopa [Recruiting]

Onset Motor Complications Using REQUIP CR (Ropinirole Controlled-Release) As Add-on Therapy To L-Dopa In Parkinson's [Active, not recruiting]

REQUIP (Ropinirole Hydrochloride)IR Long-Term Phase 4 Study [Recruiting]

A Fixed Dose Study of Ropinirole Prolonged Release as Adjunctive Treatment in Patients With Advanced Parkinson's Disease [Recruiting]

Clinical Evaluation of Ropinirole PR/XR Tablet for Adjunctive Therapy to L-dopa in Subjects With Advanced Parkinson's Disease [Recruiting]

A Placebo Controlled Trial of the Dopamine D-2 Receptor Agonist Ropinirole in Treatment of 60 Patients With Refractory Bipolar Depression. [Recruiting]

Pramipexole Conversion to Ropinirole CR [Recruiting]

Long-Term Study Of Ropinirole In Restless Legs Syndrome [Recruiting]

Ropinirole Tablets In Young Patients With Restless Legs Syndrome [Recruiting]

A Clinical Research Study Testing Ropinirole Treatment for Restless Legs Syndrome [Completed]

A Study To Investigate The Effects Of End Stage Renal Disease And Hemodialysis On The Pharmacokinetics Of Ropinirole [Completed]

Long-Term Safety Of Ropinirole XR In Patients With Restless Legs Syndrome [Completed]

12-Week Polysomnography Study of Ropinirole Controlled Release for Restless Legs Syndrome [Completed]

Clinical Evaluation of Ropinirole IR (Immediate Release) Tablets in Patients Who Are Diagnosed With Symptomatic Restless Legs Syndrome Associated With Chronic Kidney Disease (CKD) Managed With Haemodialysis (Including Haemofiltration and Haemodiafiltration) [Not yet recruiting]

Effect of Ropinirole Hydrochloride in Progressive Myoclonic Epilepsy of Unverricht-Lundborg Type [Enrolling by invitation]

Ophthalmologic Safety Study of Pramipexole IR Versus Ropinirole in Early Parkinson's Disease Patients [Recruiting]

A Single Dose, 2-Period, 2-Treatment, 2-Way Crossover Bioequivalency Study of Ropinirole 0.25 mg Tablets Und Fasted Conditions [Completed]

A Single-Dose, 2-Period, 2-Treatment, 2-Way Crossover Bioequivalency Study of Ropinirole 0.25 mg Tablets Under Fed Conditions [Completed]

Cognitive Remediation for Cocaine Dependence [Recruiting]

Clinical Evaluation of Ropinirole PR/XR Tablets in Monotherapy for Parkinson's Disease (PD) [Not yet recruiting]

Ropinirole Controlled Release (CR) as an Adjunctive Agent in the Treatment of Major Depression [Completed]

A Clinical Research Study Evaluating Ropinirole Treatment For Restless Legs Syndrome (RLS) [Completed]

Ropinirole XR (Extended Release) In Patients With Restless Legs Syndrome [Completed]

Trial of Ropinirole in Motor Recovery After Stroke [Completed]

Fibromyalgia Study In Adults [Completed]

A Trial to Compare the Efficacy of Rotigotine Transdermal Patch to That of Ropinirole on Early Morning Motor Impairment and Sleep Disorders in Subjects With Early-Stage, Idiopathic Parkinson's Disease [Completed]

Clinical Evaluation of Ropinirole CR-RLS ( SK&F106064)Tablets in Restless Legs Syndrome [Completed]

Influence of Piribedil (Clarium®) on Vigilance and Cognitive Function in Patients With Parkinson's Disease Compared to Other Non-Ergot Dopamine Agonists [Recruiting]

Safety and Tolerability Trial of Switching From Ropinirole to Rotigotine [Completed]

Effect of Ropinirole on Spinal Cord Reflexes and Restless Legs Syndrome [Completed]

Study Evaluating Sumanirole for the Treatment of the Signs and Symptoms of Early Parkinson's Disease. [Completed]

A Trial To Assess Switching From Ropinirole, Pramipexole Or Cabergoline To The Rotigotine Transdermal System In Idiopathic Parkinson's Disease [Completed]

Transdermal Lisuride: a Trial for the Treatment of Patients With Restless Legs Syndrome (RLS) [Active, not recruiting]

Investigational Parkinson's Disease In Patients Not Well Controlled On L-Dopa [Completed]

A Non-Blinded Study Demonstrating the Effectiveness and Safety of Azilect Alone or in Combination Therapy in Parkinson's Disease [Completed]

MOTION, Safinamide in Early IPD, as add-on to Dopamine Agonist [Recruiting]

Domperidone as a Treatment for Dopamine Agonist-Induced Peripheral Edema in Patients With Parkinson's Disease [Recruiting]

Lamictal Bipolar Observational Study [Completed]

Naltrexone for Impulse Control Disorders in Parkinson's Disease [Recruiting]

ACP-103 to Treat Parkinson's Disease [Completed]

Talampanel to Treat Parkinson's Disease [Completed]

Levetiracetam Treatment of L-Dopa Induced Dyskinesias [Completed]

JP-1730 to Treat Parkinson's Disease [Completed]

Study to Observe the Effect of Mirapex ER® Once-daily (QD) Versus Twice-daily (BID) [Recruiting]

Pergolide Treatment and Valvular Heart Disease [Completed]

Impact of Switching to Continuous Release Dopamine Agonists [Recruiting]

50 Hz Repetitive Transcranial Magnetic Stimulation (rTMS) for the Treatment of Parkinson's Disease [Recruiting]

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2012